Niels Reinmuth

机构：Asklepios Fachkliniken München-Gauting, Comprehensive Cancer Center Erlangen, Asklepios · ORCID：0000-0002-7369-4512

发表论文 534 篇 · 总被引 22275 次 · h-index 59

代表论文

• Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA (2025 · ESMO Open · 被引 32)
• Electric-Field Molecular Fingerprinting to Probe Cancer (2025 · ACS Central Science · 被引 12)
• Amivantamab Plus Lazertinib in Atypical EGFR -Mutated Advanced Non–Small Cell Lung Cancer: Results From CHRYSALIS-2 (2025 · Journal of Clinical Oncology · 被引 5)
• Durvalumab Plus Platinum-Etoposide in Extensive-Stage Small-Cell Lung Cancer: Outcomes in Age, Sex, and Platinum Subgroups From the Phase 3 CASPIAN Study (2025 · Clinical Lung Cancer · 被引 4)
• Treatment outcome of NSCLC patients with BRAF mutations: a retrospective, multicentre analysis within the national Network Genomic Medicine (nNGM) Lung Cancer in Germany (2025 · ESMO Open · 被引 4)
• Abstract LB260: Potential prognostic/predictive biomarkers for sacituzumab govitecan in EVOKE-01 (2025 · Cancer Research · 被引 4)